Upstream Bio (UPB) Retained Earnings (2023 - 2026)

Upstream Bio's Retained Earnings history runs 4 years deep, the most recent figure standing at -$374.8 million for Q1 2026.

• On a quarterly basis, Retained Earnings fell 156.51% year-over-year to -$374.8 million in Q1 2026; TTM through Mar 2026 was -$374.8 million, a 156.51% decrease from a year earlier, with the FY2025 full-year figure at $530000.0, down 99.92% from the prior year.
• Retained Earnings retreated to -$374.8 million in Q1 2026 per UPB's latest filing, from $530000.0 in the prior quarter.
• Across five years, Retained Earnings topped out at $666.4 million in Q2 2025 and bottomed at -$374.8 million in Q1 2026.
• The 4-year median for Retained Earnings is $6.8 million (2023), against an average of $203.8 million.
• Across the five-year window, Retained Earnings surged 13594.11% in 2024 and sank 156.51% in 2026, its largest moves.
• Year by year, Retained Earnings stood at $4.8 million in 2023, then jumped by 13594.11% to $660.6 million in 2024, then sank by 99.92% to $530000.0 in 2025, then slumped by 70819.62% to -$374.8 million in 2026.
• Per Business Quant, the three latest UPB Retained Earnings figures stand at -$374.8 million (Q1 2026), $530000.0 (Q4 2025), and $493000.0 (Q3 2025).